Drew S. Kern
University of Colorado Anschutz Medical Campus(US)University of Colorado Denver(US)
Publications by Year
Research Areas
Neurological disorders and treatments, Parkinson's Disease Mechanisms and Treatments, Genetic Neurodegenerative Diseases, Neuroscience and Neural Engineering, EEG and Brain-Computer Interfaces
Most-Cited Works
- → Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease(2022)237 cited
- → Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease(2015)141 cited
- → Long-term activity in upper- and lower-limb muscles of humans(2001)131 cited
- → Biocompatibility of poly(ethylene glycol)‐based hydrogels in the brain: An analysis of the glial response across space and time(2010)116 cited
- → Biocompatibility of PEG-Based Hydrogels in Primate Brain(2008)100 cited
- → The administration of BDNF and GDNF to the brain via PLGA microparticles patterned within a degradable PEG‐based hydrogel: Protein distribution and the glial response(2011)94 cited